UGI / HPB NSSG Clinical Guidelines Contents - SWCN

This paper outlines the current management strategy for patients with hepatocellular carcinoma (HCC) who are referred to the Bristol Central HPB MDT. Liver cancer services are not currently subject to NICE or IOG guidance, though it is likely that this will happen in the future. ................
................